182 related articles for article (PubMed ID: 28536795)
1. Exploration of alginates as potential stabilizers of nanosuspension.
Guan J; Zhang Y; Liu Q; Zhang X; Chokshi R; Mao S
AAPS PharmSciTech; 2017 Nov; 18(8):3172-3181. PubMed ID: 28536795
[TBL] [Abstract][Full Text] [Related]
2. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
Gajera BY; Shah DA; Dave RH
Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
[TBL] [Abstract][Full Text] [Related]
3. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
Sun W; Ni R; Zhang X; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
[TBL] [Abstract][Full Text] [Related]
4. Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.
Ye X; Patil H; Feng X; Tiwari RV; Lu J; Gryczke A; Kolter K; Langley N; Majumdar S; Neupane D; Mishra SR; Repka MA
AAPS PharmSciTech; 2016 Feb; 17(1):78-88. PubMed ID: 26283197
[TBL] [Abstract][Full Text] [Related]
5. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
6. Application of spray granulation for conversion of a nanosuspension into a dry powder form.
Bose S; Schenck D; Ghosh I; Hollywood A; Maulit E; Ruegger C
Eur J Pharm Sci; 2012 Aug; 47(1):35-43. PubMed ID: 22565066
[TBL] [Abstract][Full Text] [Related]
7. Ginkgolides-loaded soybean phospholipid-stabilized nanosuspension with improved storage stability and in vivo bioavailability.
Wang P; Cao X; Chu Y; Wang P
Colloids Surf B Biointerfaces; 2019 Sep; 181():910-917. PubMed ID: 31382340
[TBL] [Abstract][Full Text] [Related]
8. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
Miao X; Sun C; Jiang T; Zheng L; Wang T; Wang S
J Pharm Pharm Sci; 2011; 14(2):196-214. PubMed ID: 21733409
[TBL] [Abstract][Full Text] [Related]
9. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
10. Influence of stabilizer type and concentration on the lung deposition and retention of resveratrol nanosuspension-in-microparticles.
Liu Q; Guan J; Sun Z; Shen X; Li L; Jin L; Mao S
Int J Pharm; 2019 Oct; 569():118562. PubMed ID: 31351178
[TBL] [Abstract][Full Text] [Related]
11. Preparation and solidification of redispersible nanosuspensions.
Zhang X; Guan J; Ni R; Li LC; Mao S
J Pharm Sci; 2014 Jul; 103(7):2166-2176. PubMed ID: 24840928
[TBL] [Abstract][Full Text] [Related]
12. In vivo absorption comparison of nanotechnology-based silybin tablets with its water-soluble derivative.
Xu D; Ni R; Sun W; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Apr; 41(4):552-9. PubMed ID: 24495272
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
Kassem MAA; ElMeshad AN; Fares AR
AAPS PharmSciTech; 2017 May; 18(4):983-996. PubMed ID: 27506564
[TBL] [Abstract][Full Text] [Related]
14. Improved oral bioavailability of core-shell structured beads by redispersion of the shell-forming nanoparticles: preparation, characterization and in vivo studies.
Yao Q; Tao X; Tian B; Tang Y; Shao Y; Kou L; Gou J; Li X; Yin T; Tang X
Colloids Surf B Biointerfaces; 2014 Jan; 113():92-100. PubMed ID: 24060933
[TBL] [Abstract][Full Text] [Related]
15. Rutin nanosuspension for potential management of osteoporosis: effect of particle size reduction on oral bioavailability,
Gera S; Pooladanda V; Godugu C; Swamy Challa V; Wankar J; Dodoala S; Sampathi S
Pharm Dev Technol; 2020 Oct; 25(8):971-988. PubMed ID: 32403972
[TBL] [Abstract][Full Text] [Related]
16. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
[TBL] [Abstract][Full Text] [Related]
17. Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies.
Lu T; Sun Y; Ding D; Zhang Q; Fan R; He Z; Wang J
AAPS PharmSciTech; 2017 Feb; 18(2):473-480. PubMed ID: 27116201
[TBL] [Abstract][Full Text] [Related]
18. Advantages of celecoxib nanosuspension formulation and transformation into tablets.
Dolenc A; Kristl J; Baumgartner S; Planinsek O
Int J Pharm; 2009 Jul; 376(1-2):204-12. PubMed ID: 19426794
[TBL] [Abstract][Full Text] [Related]
19. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.
Karakucuk A; Celebi N; Teksin ZS
Eur J Pharm Sci; 2016 Dec; 95():111-121. PubMed ID: 27181836
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: Physicochemical and pharmacokinetic investigation.
Geng T; Banerjee P; Lu Z; Zoghbi A; Li T; Wang B
Eur J Pharm Sci; 2017 Nov; 109():200-208. PubMed ID: 28811130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
